Features of antibacterial therapy of acute purulent sinusitis and acute purulent otitis media
https://doi.org/10.21518/2079-701X-2018-6-78-82
Abstract
The article presents modern views on the microbiological findings of acute purulent sinusitis and acute purulent otitis media in identified in conjunction with clinical course. It shows the role of Haemophilus influenzae in the development of a protracted, recurrent, and chronic course of the process. The therapeutic potentials of Pancef (cefixim) for the treatment and prevention of these conditions are presented.
About the Author
A. V. Gurov
N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Sverzhevskiy Otorhinolaryngology Healthcare Research Institute of the Moscow Department of Healthcare
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
References
1. Guidelines on focal infection in otorhinolaryngology. Edited by Palchun VT, Kryukov AI, Magomedov MM. M.: GEOTAR-MEDIA, 2015. 224 p.
2. Deryugina OV, Chumakov FI. Orbital and intra-cranial complications of inflammatory diseases of the nose and paranasal sinuses in adults and children. M.: MONIKI, 2001, 116 p.
3. Kunelskaya NL, Gurov AV, Kudryavtseva YuS, Kafarskaya LI, Izotova GN. Efficacy of cefixim in patients with acute purulent sinusitis and exacerbation of chronic purulent sinusitis. Vestnik Otorinolaringologii, 2008, 6: 55-58.
4. Kryukov AI, Shubin MN. Appropriate antibiotic therapy for acute and sluggish rhinosinusitis. Consilium medicum, 2001, 3 (8): 358-361.
5. WHO. Global antimicrobial resistance surveillance system (GLASS) report: Early implementation 2016-2017. [электронный ресурс – дата обращения 10.03.18]. / WHO. Global Antimicrobial Resistance Monitoring System (GLASS) report: Early implementation 2016-2017. [Electronic resource - accessed date 10.03.18].
6. Kryukov AI, Kunleskaya NL, Gurov AV, Elchueva ZG, Isotova GN, Muratov DL, Sokolov SС. Topical issues of clinical picture and therapy of acute purulent otitis media. Meditsinsky Sovet, 2015, 7: 8-11.
7. Palchun VT, Lucichin LA. Advisability and efficacy of antibacterial therapy in ENT practice. Vestnik Otorinolaringologii, 2006, 3: 27-30.
8. Zubkov MN. The algorithm for the treatment of acute and chronic infections of the upper and lower respiratory tract. RMG, 2009, 17 (2): 123-131.
9. Lopatin AS, Aleksandrova IA, Gamov VP, Detochka YaV. Rational pharmacotherapy for ear, throat and nose disorders: A guide for practitioners. M.: Litterra, 2011: 48-64.
10. Strachunsky LS, Kozlov SN. Modern antimicrobial chemotherapy. A guide for practitioners. M.: Borges, 2002. 432 p.
11. Block SL, Schwartz R.H. Changes noted in bacteriology of OAM since PCV7 (text). Infectious diseases in children, 2003, Aug, 8-16.
12. Brink AJ et al. Guideline for the management of upper respiratory tract infections (text). S Afr Med J, 2004 Jun, 94(6Pt2): 475-83.
13. England JK, Bauernfeind A, Levenstein J et al. A multicentre randomised comparison of cefixime versus co-trimoxazole in uncomplicated urinary tract infections. Workshop 15th International Congress of Chemotherapy. Advances in experimental and clinical chemotherapy, 1988: 53–60.
14. Iravani A, Richard GA, Johnson D et al. Am J Medicine, 1988, 85(Suppl. 3A): 17–85.
15. Ludwig E. Cefixime in the treatment of respiratory and urinary tract infections. Chemotherapy. 1998, 44(suppl 1): 31-34.
16. Patient Information Leaflet for Pancef®.
Review
For citations:
Gurov AV. Features of antibacterial therapy of acute purulent sinusitis and acute purulent otitis media. Meditsinskiy sovet = Medical Council. 2018;(6):78-82. (In Russ.) https://doi.org/10.21518/2079-701X-2018-6-78-82
Views:
640
Email this article 